News
16h
Zacks.com on MSNCatalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3d
Zacks.com on MSNCPRX or NBIX: Which Is the Better Value Stock Right Now?But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model ...
Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Investors looking for stocks in the Medical - Drugs sector might want to consider either Catalyst Pharmaceutical (CPRX) or Neurocrine Biosciences (NBIX). But which of these two stocks is more ...
17h
Zacks Investment Research on MSNHere's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
(CPRX) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing. A solid price increase over a period of 12 weeks reflects investors' continued willingness ...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Analysts at Zacks Research increased their FY2025 earnings per share (EPS) estimates for Catalyst Pharmaceuticals in a report ...
4d
Zacks Investment Research on MSNCatalyst (CPRX) Is a Great Choice for 'Trend' Investors, Here's WhyWhile "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...
Detailed price information for Catalyst Pharm Inc (CPRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results